Abstract
Mycoplasma genitalium is characterized by a small genome and a lack of a cell wall, contributing to its unique biology. It is associated with reproductive tract infections, including non-gonococcal urethritis and pelvic inflammatory disease. It is nearly as common as chlamydia in most studies from high-income countries. The emergence of antimicrobial resistance in M. genitalium raises concern about the long-term efficacy of current therapeutic strategies. Understanding its genomic intricacies and pathogenic mechanisms is crucial for developing targeted interventions to address the growing public health impact of this elusive microbe.
Original language | English |
---|---|
Article number | 001984 |
Journal | Journal of Medical Microbiology |
Volume | 74 |
Issue number | 4 |
DOIs | |
Publication status | Published - 4 Apr 2025 |
Keywords
- fluoroquinolones
- macrolide resistance
- non-gonococcal urethritis
- Genome, Bacterial
- Humans
- Reproductive Tract Infections - microbiology - epidemiology
- Urethritis - microbiology
- Drug Resistance, Bacterial
- Mycoplasma genitalium - genetics - pathogenicity - drug effects - physiology
- Mycoplasma Infections - microbiology - epidemiology - drug therapy
- Anti-Bacterial Agents - pharmacology - therapeutic use
- Female
- Pelvic Inflammatory Disease - microbiology